Axogen (AXGN) Return on Capital Employed Growth (5y) (2016 - 2026)
Axogen (AXGN) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Axogen | 2.09 Bn | 1.99 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 787.00 |
| Dec 31, 2025 | 924.00 |
| Mar 31, 2025 | 2,259.00 |
| Dec 31, 2024 | 2,155.00 |
| Sep 30, 2024 | 1,645.00 |
| Jun 30, 2024 | 1,264.00 |
| Mar 31, 2024 | 680.00 |
| Dec 31, 2023 | 88.00 |
| Sep 30, 2023 | -331.00 |
| Jun 30, 2023 | -145.00 |
| Mar 31, 2023 | 847.00 |
| Dec 31, 2022 | 429.00 |
| Sep 30, 2022 | 1,117.00 |
| Jun 30, 2022 | 862.00 |
| Mar 31, 2022 | 857.00 |
| Dec 31, 2021 | 1,582.00 |
| Sep 30, 2021 | 1,662.00 |
| Jun 30, 2021 | 1,980.00 |
| Mar 31, 2021 | 1,803.00 |
| Dec 31, 2020 | 1,314.00 |